ENTRY       D04034                      Drug
NAME        Chlorpromazine phenolphthalinate (JAN);
            Wintermin (TN)
FORMULA     C20H16O4. C17H19ClN2S
EXACT_MASS  638.2006
MOL_WEIGHT  639.2028
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01465  alpha-Adrenergic receptor antagonist
               DG01460  alpha2-Adrenergic receptor antagonist
            Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG01491  Muscarinic cholinergic receptor antagonist
             DG03200  Antipsychotic agent
              DG01905  Phenothiazine antipsychotics
            Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
REMARK      Therapeutic category: 1171
            ATC code: N05AA01
            Chemical structure group: DG00867
            Product (DG00867): D00789<JP/US> D04034<JP>
EFFICACY    Antipsychotic
COMMENT     Phenothiazine derivative
TARGET      HTR2 [HSA:3356 3357 3358] [KO:K04157]
            HRH1 [HSA:3269] [KO:K04149]
            ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
            DRD2 [HSA:1813] [KO:K04145]
            CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]
  PATHWAY   hsa04080(1128+1129+1131+1132+1133+150+151+152+1813+3269+3356+3357+3358)  Neuroactive ligand-receptor interaction
            hsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse
            hsa04726(3356+3357+3358)  Serotonergic synapse
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION CYP inhibition: CYP2D6 [HSA:1565]
STR_MAP     map07028  Antipsychotics
            map07029  Antipsychotics - phenothiazines
            map07212  Histamine H1 receptor antagonists
            map07213  Dopamine receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AA Phenothiazines with aliphatic side-chain
                 N05AA01 Chlorpromazine
                  D04034  Chlorpromazine phenolphthalinate (JAN) &lt;JP&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              1st Generation/Typical
               Chlorpromazine
                D04034  Chlorpromazine phenolphthalinate (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1171  Chlorpromazines
                 D04034  Chlorpromazine phenolphthalinate (JAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01460  alpha2-Adrenergic receptor antagonist
                 DG00867  Chlorpromazine
                  D04034  Chlorpromazine phenolphthalinate
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00867  Chlorpromazine
                 D04034  Chlorpromazine phenolphthalinate
              DG01491  Muscarinic cholinergic receptor antagonist
               DG00867  Chlorpromazine
                D04034  Chlorpromazine phenolphthalinate
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00867  Chlorpromazine
                 D04034  Chlorpromazine phenolphthalinate
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00867  Chlorpromazine
                 D04034  Chlorpromazine phenolphthalinate
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00867  Chlorpromazine
                D04034  Chlorpromazine phenolphthalinate
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00867  Chlorpromazine
                D04034  Chlorpromazine phenolphthalinate
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D04034  Chlorpromazine phenolphthalinate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Acetylcholine (muscarinic)
                CHRM
                 D04034  Chlorpromazine phenolphthalinate (JAN) &lt;JP&gt;
               Adrenaline
                ADRA2
                 D04034  Chlorpromazine phenolphthalinate (JAN) &lt;JP&gt;
               Dopamine
                DRD2
                 D04034  Chlorpromazine phenolphthalinate (JAN) &lt;JP&gt;
               Histamine
                HRH1
                 D04034  Chlorpromazine phenolphthalinate (JAN) &lt;JP&gt;
               Serotonin
                HTR2
                 D04034  Chlorpromazine phenolphthalinate (JAN) &lt;JP&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04034
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01460  alpha2-Adrenergic receptor antagonist
                 DG00867  Chlorpromazine
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00867  Chlorpromazine
              DG01491  Muscarinic cholinergic receptor antagonist
               DG00867  Chlorpromazine
              DG03200  Antipsychotic agent
               DG01905  Phenothiazine antipsychotics
                DG00867  Chlorpromazine
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00867  Chlorpromazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00867  Chlorpromazine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00867  Chlorpromazine
DBLINKS     PubChem: 47205999
            LigandBox: D04034
ATOM        45
            1   C8x C     1.7565  -18.6515
            2   C8x C     1.7565  -20.0541
            3   C8x C     2.9711  -20.7554
            4   C8y C     4.1859  -20.0541
            5   C8y C     4.1859  -18.6515
            6   C8x C     2.9711  -17.9502
            7   S2x S     5.4006  -20.7554
            8   C8y C     6.6153  -20.0541
            9   C8y C     6.6153  -18.6515
            10  N4y N     5.4006  -17.9502
            11  C8x C     7.8301  -20.7554
            12  C8x C     9.0447  -20.0541
            13  C8y C     9.0447  -18.6515
            14  C8x C     7.8301  -17.9502
            15  C1b C     5.4006  -16.5475
            16  C1b C     6.6174  -15.8450
            17  C1b C     7.8161  -16.5373
            18  N1c N     9.0052  -15.8508
            19  C1a C    10.1989  -16.5403
            20  C1a C     9.0054  -14.4438
            21  X   Cl   10.2635  -17.9479
            22  C8x C    13.3000  -18.5500
            23  C8y C    13.3000  -19.9500
            24  C8x C    14.5124  -20.6500
            25  C8x C    15.7249  -19.9500
            26  C8y C    15.7249  -18.5500
            27  C8x C    14.5124  -17.8500
            28  C8x C    18.1497  -19.9500
            29  C8y C    18.1497  -18.5500
            30  C1c C    16.9373  -17.8500
            31  C8x C    19.3622  -20.6500
            32  C8y C    20.5746  -19.9500
            33  C8x C    20.5746  -18.5500
            34  C8x C    19.3622  -17.8500
            35  C8y C    16.9373  -16.4500
            36  C8y C    18.1518  -15.7488
            37  C8x C    18.1518  -14.3488
            38  C8x C    16.9393  -13.6488
            39  C8x C    15.7249  -14.3500
            40  C8x C    15.7249  -15.7500
            41  O1a O    12.0876  -20.6500
            42  O1a O    21.7911  -20.6523
            43  C6a C    19.5518  -15.7488
            44  O6a O    20.2466  -16.9527
            45  O6a O    20.2457  -14.5468
BOND        49
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    8  11 2
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16    9  14 2
            17   10  15 1
            18   15  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   18  20 1
            23   13  21 1
            24   22  23 2
            25   23  24 1
            26   24  25 2
            27   25  26 1
            28   26  27 2
            29   22  27 1
            30   28  29 1
            31   29  30 1
            32   26  30 1
            33   28  31 2
            34   31  32 1
            35   32  33 2
            36   33  34 1
            37   29  34 2
            38   30  35 1
            39   35  36 2
            40   36  37 1
            41   37  38 2
            42   38  39 1
            43   39  40 2
            44   35  40 1
            45   23  41 1
            46   32  42 1
            47   36  43 1
            48   43  44 2
            49   43  45 1
///
